Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease
- 1 April 2000
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 35 (4) , 611-616
- https://doi.org/10.1016/s0272-6386(00)70006-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Influence of dialysis with polyamide vs haemophan haemodialysis on monokines and complement activation during a 4-month long-term studyNephrology Dialysis Transplantation, 1999
- Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failureAmerican Journal of Kidney Diseases, 1995
- Contributing factors to the inhibition of phagocytosis in hemodialyzed patientsKidney International, 1993
- Cytokines: Agents provocateurs in hemodialysis?Kidney International, 1992
- Elevated circulating levels of interleukin-6 in patients with chronic renal failureKidney International, 1991
- Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failureKidney International, 1990
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complementKidney International, 1990
- Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complementKidney International, 1988
- Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.Journal of Clinical Investigation, 1987